Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04609657 · ClinicalTrials.gov registry record · NA
Liking Adaptation to Beverages With Varying Sweetness Levels After Prolonged Exposure
A NA study, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
NCT04609657 is a NA study that has completed, run by PepsiCo Global R&D. The registered enrollment target is 168 participants.
The verdict
NCT04609657, a NA study, has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
Study Summary
This is a double-blind, controlled, parallel, randomized sensory study. The study will consist of two cohorts; habitual regular full-calorie Carbonated Soft Drink (CSD) consumers and habitual low-calorie CSD consumers. Each cohort will be randomized to one of 3 interventions for six months (24 weeks): * Intervention 1: Control (full sweetness) beverage * Intervention 2: Step-wise sweetness reduction series of beverages * Intervention 3: Moderate sweetness (reduced sweetness) beverage The primary outcome is to assess the perception changes in sweetness (magnitude scale) and sweetness liking (Likert scale) of a test product and a control product over a period of six months. The study endeavors to explore whether consumers of sweetened carbonated beverages can adapt liking to lower sweetness beverages after prolonged exposure of daily consumption of beverages with step-wise reduction of sweetness, or maintenance at reduced (moderate) sweetness. Additional analysis will be to assess dietary compensation for sweetness in the step-wise and moderate reduction arms compared to the control arms (the full calorie and low calorie control beverages). Dietary analysis of calories and intakes of total sugar, added sugar, and servings of low-/non-calorie sweeteners will be assessed using a 3-day diet record pre-intervention and monthly for 6 months.
Interventions
- OTHER Flavored carbonated soft drink (CSD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2020-11-10 |
| Est. Completion | 2021-05-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04609657
The ClinicalTrials.gov registry entry for NCT04609657 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PepsiCo Global R&D, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flavored carbonated soft drink (CSD) is the first listed.
NCT04609657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04609657 about?
NCT04609657 is a clinical study titled "Liking Adaptation to Beverages With Varying Sweetness Levels After Prolonged Exposure". This is a double-blind, controlled, parallel, randomized sensory study. The study will consist of two cohorts; habitual regular full-calorie Carbonated Soft Drink (CSD) consumers and habitual low-calorie CSD consumers. Each cohort will be randomized to one of 3 interventions for six months (24 weeks...
What is the current status of trial NCT04609657?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2020-11-10. Estimated completion is 2021-05-25.
What interventions are being tested in trial NCT04609657?
The interventions under investigation include: Flavored carbonated soft drink (CSD) (OTHER).
Who is sponsoring clinical trial NCT04609657?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.